http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105853355-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4711b7defc1422cdb7f86d2c95657bf
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0441be62cae8c78aeb0559e65ce8f1c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa177aa5bd89486a969de22b7e237ca7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc34363caa044168d2508ec5af2807ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf0e67dd204382bbabbd57ce31dadff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf63a6ca0afd591378629741447db6b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd3d911503f0954506f7369dff83f0fb
publicationDate 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105853355-A
titleOfInvention Micelle preparation entrapped with binding peptide polymer with specific anti-cancer activity
abstract The present invention belongs to the field of pharmaceutical preparations, and relates to a polypeptide drug delivery system, particularly to a micelle preparation entrapped with binding peptide polymer with specific anti-cancer activity. The drug delivery system consists of a targeted functional material, an amphiphilic block copolymer and a binding peptide. By entrapping a binding peptide capable of restoring the activity of a tumor suppressor protein p53, the binding peptide is delivered into cancer cells to exert the activity of inhibiting tumor cell growth and increase targeted anti-cancer effect; and the binding peptide has better anti-cancer effect by combination with temozolomide. By in vivo and in vitro active valuation, the drug delivery system is proved to be able to successfully deliver binding peptides to the target site and send binding peptides into the target cells, and has clear therapeutic effect.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111909241-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113845598-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109731104-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111909241-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019165576-A1
priorityDate 2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17248
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID852825
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID314856
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426178219
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540378
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556073
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30637
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104802
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395609
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID742141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11433190
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02701
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID514225
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID398466
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4194
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17246
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID304798

Total number of triples: 82.